Vitrolife
Vitrolife AB (publ) completes the acquisition of eFertility
eFertility is an innovative system and software company transforming IVF clinic management with its cutting-edge solutions: eWitness (witnessing system to track and trace each step of the IVF procedure) and eBase (a specialised EMR that is compatible with hospital information systems). eFertility has a leading presence in the Netherlands and is rapidly expanding across Europe. In 2023, the company had revenues of EUR 1.5 million with a strong sales pipeline demonstrating the increased demand for witnessing systems in the IVF market. eFertility will be reported under the Technologies business area.
Gothenburg, May 22, 2024
VITROLIFE AB (publ)
Bronwyn Brophy O’Connor, CEO
The information was submitted for publication, through the agency of the contact persons set out above, at 22-05-2024 13:30 CET.
| Datum | 2024-05-22, kl 13:30 |
| Källa | Cision |
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.